These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 11442249

  • 1. Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus.
    Wong RJ, Kim SH, Joe JK, Shah JP, Johnson PA, Fong Y.
    J Am Coll Surg; 2001 Jul; 193(1):12-21. PubMed ID: 11442249
    [Abstract] [Full Text] [Related]

  • 2. Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses.
    McAuliffe PF, Jarnagin WR, Johnson P, Delman KA, Federoff H, Fong Y.
    J Gastrointest Surg; 2000 Jul; 4(6):580-8. PubMed ID: 11307092
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of oncolytic herpesvirus NV1020 can be enhanced by combination with chemotherapeutics in colon carcinoma cells.
    Gutermann A, Mayer E, von Dehn-Rothfelser K, Breidenstein C, Weber M, Muench M, Gungor D, Suehnel J, Moebius U, Lechmann M.
    Hum Gene Ther; 2006 Dec; 17(12):1241-53. PubMed ID: 17117895
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer.
    Bennett JJ, Delman KA, Burt BM, Mariotti A, Malhotra S, Zager J, Petrowsky H, Mastorides S, Federoff H, Fong Y.
    Cancer Gene Ther; 2002 Nov; 9(11):935-45. PubMed ID: 12386832
    [Abstract] [Full Text] [Related]

  • 6. Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma.
    Goebel EA, Davidson BL, Graham SM, Kern JA.
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):331-6. PubMed ID: 9781985
    [Abstract] [Full Text] [Related]

  • 7. Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures.
    Dias JD, Guse K, Nokisalmi P, Eriksson M, Chen DT, Diaconu I, Tenhunen M, Liikanen I, Grénman R, Savontaus M, Pesonen S, Cerullo V, Hemminki A.
    Eur J Cancer; 2010 Feb; 46(3):625-35. PubMed ID: 20006487
    [Abstract] [Full Text] [Related]

  • 8. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
    Jarnagin WR, Zager JS, Hezel M, Stanziale SF, Adusumilli PS, Gonen M, Ebright MI, Culliford A, Gusani NJ, Fong Y.
    Cancer Gene Ther; 2006 Mar; 13(3):326-34. PubMed ID: 16138120
    [Abstract] [Full Text] [Related]

  • 9. Oncolysis using herpes simplex virus type 1 engineered to express cytosine deaminase and a fusogenic glycoprotein for head and neck squamous cell carcinoma.
    Price DL, Lin SF, Han Z, Simpson G, Coffin RS, Wong J, Li S, Fong Y, Wong RJ.
    Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):151-8. PubMed ID: 20157061
    [Abstract] [Full Text] [Related]

  • 10. Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.
    Chahlavi A, Todo T, Martuza RL, Rabkin SD.
    Neoplasia; 1999 Jun; 1(2):162-9. PubMed ID: 10933051
    [Abstract] [Full Text] [Related]

  • 11. HSV-tk gene therapy in head and neck squamous cell carcinoma. Enhancement by the local and distant bystander effect.
    Wilson KM, Stambrook PJ, Bi WL, Pavelic ZP, Pavelic L, Gluckman JL.
    Arch Otolaryngol Head Neck Surg; 1996 Jul; 122(7):746-9. PubMed ID: 8663948
    [Abstract] [Full Text] [Related]

  • 12. Ultrasound as a method to enhance antitumor ability of oncolytic herpes simplex virus for head and neck cancer.
    Okunaga S, Takasu A, Meshii N, Imai T, Hamada M, Iwai S, Yura Y.
    Cancer Gene Ther; 2015 Apr; 22(3):163-8. PubMed ID: 25656776
    [Abstract] [Full Text] [Related]

  • 13. Lister vaccine strain of vaccinia virus armed with the endostatin-angiostatin fusion gene: an oncolytic virus superior to dl1520 (ONYX-015) for human head and neck cancer.
    Tysome JR, Wang P, Alusi G, Briat A, Gangeswaran R, Wang J, Bhakta V, Fodor I, Lemoine NR, Wang Y.
    Hum Gene Ther; 2011 Sep; 22(9):1101-8. PubMed ID: 21361787
    [Abstract] [Full Text] [Related]

  • 14. Effective treatment of human breast tumor in a mouse xenograft model with herpes simplex virus type 1 specifying the NV1020 genomic deletion and the gBsyn3 syncytial mutation enabling high viral replication and spread in breast cancer cells.
    Israyelyan AH, Melancon JM, Lomax LG, Sehgal I, Leuschner C, Kearney MT, Chouljenko VN, Baghian A, Kousoulas KG.
    Hum Gene Ther; 2007 May; 18(5):457-73. PubMed ID: 17536976
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma.
    Shin EJ, Wanna GB, Choi B, Aguila D, Ebert O, Genden EM, Woo SL.
    Laryngoscope; 2007 Feb; 117(2):210-4. PubMed ID: 17204993
    [Abstract] [Full Text] [Related]

  • 16. Nectin-1 expression by squamous cell carcinoma is a predictor of herpes oncolytic sensitivity.
    Yu Z, Adusumilli PS, Eisenberg DP, Darr E, Ghossein RA, Li S, Liu S, Singh B, Shah JP, Fong Y, Wong RJ.
    Mol Ther; 2007 Jan; 15(1):103-13. PubMed ID: 17164781
    [Abstract] [Full Text] [Related]

  • 17. Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma.
    Cooper T, Biron VL, Fast D, Tam R, Carey T, Shmulevitz M, Seikaly H.
    J Otolaryngol Head Neck Surg; 2015 Feb 24; 44(1):8. PubMed ID: 25890191
    [Abstract] [Full Text] [Related]

  • 18. Intratumoral injection of herpes simplex virus HF10 in recurrent head and neck squamous cell carcinoma.
    Fujimoto Y, Mizuno T, Sugiura S, Goshima F, Kohno S, Nakashima T, Nishiyama Y.
    Acta Otolaryngol; 2006 Oct 24; 126(10):1115-7. PubMed ID: 16923721
    [Abstract] [Full Text] [Related]

  • 19. Treatment of aggressive thyroid cancer with an oncolytic herpes virus.
    Yu Z, Eisenberg DP, Singh B, Shah JP, Fong Y, Wong RJ.
    Int J Cancer; 2004 Nov 10; 112(3):525-32. PubMed ID: 15382081
    [Abstract] [Full Text] [Related]

  • 20. Replication-competent herpes virus NV1020 as direct treatment of pleural cancer in a rat model.
    Ebright MI, Zager JS, Malhotra S, Delman KA, Weigel TL, Rusch VW, Fong Y.
    J Thorac Cardiovasc Surg; 2002 Jul 10; 124(1):123-9. PubMed ID: 12091817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.